β1而非β3肾上腺素能受体可能是人棕色脂肪细胞代谢的主要调节因子
研究在人棕色脂肪细胞模型(TERT-hBA)和新鲜人棕色脂肪组织(BAT)活检中评估不同β肾上腺素能受体(ADRB)亚型对解偶联蛋白1(UCP1)诱导和脂解的作用。结果显示TERT-hBA与人BAT活检均以ADRB1为主;双丁酰环磷酸腺苷(dbcAMP)、异丙肾上腺素(ISO)和多巴酚丁胺刺激UCP1表达与甘油释放,而ADRB2、ADRB3激动剂无此作用;选择性敲低ADRB1显著减弱ISO诱导的UCP1表达。作者认为人BAT的UCP1表达可能主要经ADRB1调控,与啮齿类不同。
要点
- TERT-hBA脂肪细胞与人BAT活检中占主导的ADRB亚型为ADRB1。
- 多巴酚丁胺(ADRB1激动剂)可刺激UCP1 mRNA表达和甘油释放。
- 选择性敲低ADRB1显著减弱ISO诱导的UCP1表达。
核心结论
- 人棕色脂肪中UCP1与脂解的肾上腺素能刺激可能主要经ADRB1介导,与啮齿类不同,这一发现可能对未来以ADRB激动剂激活人BAT的治疗有启示。
研究设计与样本
- 采用人BAT细胞模型(TERT-hBA),检测亚型特异性ADRB激动剂及受体敲低对UCP1 mRNA水平和脂解(甘油释放)的影响,并用RT-qPCR检测新鲜人BAT活检与TERT-hBA中ADRB1、ADRB2、ADRB3的表达。
主要发现
- TERT-hBA脂肪细胞和BAT活检中占主导的ADRB亚型为ADRB1。
- TERT-hBA中UCP1 mRNA表达被dbcAMP刺激11.0倍、被ISO刺激8.0至8.4倍、被多巴酚丁胺刺激6.1至12.7倍,而普瑞特罗、CL314.432或米拉贝隆均未影响UCP1。
- dbcAMP、ISO和多巴酚丁胺刺激甘油释放,而ADRB2和ADRB3激动剂不影响脂解。
- 选择性敲低ADRB1显著减弱ISO诱导的UCP1表达。
临床怎么用
- 作者认为这些发现可能对未来作为人BAT激活治疗化合物的ADRB激动剂有启示。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Brown adipose tissue (BAT) activation in humans has gained interest as a potential target for treatment of obesity and insulin resistance. In rodents, BAT is primarily induced through beta-3 adrenergic receptor (ADRB3) stimulation, whereas the primary beta adrenergic receptors (ADRBs) involved in human BAT activation are debated. We evaluated the importance of different ADRB subtypes for uncoupling protein 1 (UCP1) induction in human brown adipocytes. METHODS: A human BAT cell model (TERT-hBA) was investigated for subtype-specific ADRB agonists and receptor knockdown on UCP1 mRNA levels and lipolysis (glycerol release). In addition, fresh human BAT biopsies and TERT-hBA were evaluated for expression of ADRB1, ADRB2, and ADRB3 using RT-qPCR. RESULTS: The predominant ADRB subtype in TERT-hBA adipocytes and BAT biopsies was ADRB1. In TERT-hBA, UCP1 mRNA expression was stimulated 11.0-fold by dibutyryl cAMP (dbcAMP), 8.0-fold to 8.4-fold by isoproterenol (ISO; a pan-ADRB agonist), and 6.1-fold to 12.7-fold by dobutamine (ADRB1 agonist), whereas neither procaterol (ADRB2 agonist), CL314.432, or Mirabegron (ADRB3 agonists) affected UCP1. Similarly, dbcAMP, ISO, and dobutamine stimulated glycerol release, whereas lipolysis was unaffected by ADRB2 and ADRB3 agonists. Selective knockdown of ADRB1 significantly attenuated ISO-induced UCP1 expression. CONCLUSION: The adrenergic stimulation of UCP1 and lipolysis may mainly be mediated through ADRB1. Moreover, ADRB1 is the predominant ADRB in both TERT-hBA and human BAT biopsies. Thus, UCP1 expression in human BAT may, unlike in rodents, primarily be regulated by ADRB1. These findings may have implications for ADRB agonists as future therapeutic compounds for human BAT activation.
引用
- Riis-Vestergaard MJ, Richelsen B, Bruun JM, et al. Beta-1 and Not Beta-3 Adrenergic Receptors May Be the Primary Regulator of Human Brown Adipocyte Metabolism. J Clin Endocrinol Metab. 2020. PMID: 31867674. doi:10.1210/clinem/dgz298
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。